Coherus Oncology
CHRS
78 hedge funds and large institutions have $324M invested in Coherus Oncology in 2015 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 29 increasing their positions, 22 reducing their positions, and 14 closing their positions.
32% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 22
21% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 14
4% more funds holding
Funds holding: 75 → 78 (+3)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
26% less capital invested
Capital invested by funds: $435M → $324M (-$111M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1.47M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$31.8M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$6.15M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
+$4.87M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$4.86M |
| 5 |
CGI
CI Global Investments
Oakland,
California
|
+$4.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$7.58M |
| 2 |
PA
Perceptive Advisors
New York
|
-$7.48M |
| 3 |
JP Morgan Chase
New York
|
-$4.56M |
| 4 |
Millennium Management
New York
|
-$3.84M |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$3.39M |
CHRS Hedge Fund Activity: Q3 2015 in Review
78 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Coherus Oncology (CHRS) for Q3 2015, worth a combined $324M — down 26% from $435M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new CHRS positions and 14 closed out — a net gain of 3 holders — while 29 added to existing stakes and 22 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $31.8M. The largest seller was Rock Springs Capital Management, cutting an estimated $7.58M.
- 78 institutional investors held Coherus Oncology (CHRS) as of Q3 2015, up from 75 in Q2 2015.
- Funds reported $324M of Coherus Oncology stock for Q3 2015, down 26% quarter-over-quarter.
- 17 funds opened new Coherus Oncology positions in Q3 2015 and 14 closed out, a net change of +3 holders.
- The largest Coherus Oncology buyer in Q3 2015 was Fidelity Investments, an estimated $31.8M added.
- The largest Coherus Oncology seller in Q3 2015 was Rock Springs Capital Management, an estimated $7.58M sold.
Based on aggregated 13F filings for Q3 2015.